The Effect of Phloroglucinol, A Component of Ecklonia cava Extract, on Hepatic Glucose Production
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Ji-Young | - |
dc.contributor.author | Choi, Hojung | - |
dc.contributor.author | Jun, Hee-Sook | - |
dc.date.available | 2020-02-27T19:41:55Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-04 | - |
dc.identifier.issn | 1660-3397 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/6290 | - |
dc.description.abstract | Phloroglucinol is a phenolic compound that is one of the major compounds in Ecklonia cava (brown alga). It has many pharmacological activities, but its anti-diabetic effect is not yet fully explored. In this study, we investigated the effect of phloroglucinol on the control of blood glucose levels and the regulation of hepatic glucose production. Phloroglucinol significantly improved glucose tolerance in male C57BL/6J mice fed a high fat diet (HFD) and inhibited glucose production in mouse primary hepatocytes. The expression of phosphoenol pyruvate carboxykinase (PEPCK) and glucose-6-phosphatase mRNA and protein (G6Pase), enzymes involved in gluconeogenesis, were inhibited in liver tissue from phloroglucinol-treated mice and in phloroglucinol-treated HepG2 cells. In addition, phloroglucinol treatment increased phosphorylated AMP-activated protein kinase (AMPK)alpha in HepG2 cells. Treatment with compound C, an AMPK alpha inhibitor, inhibited the increase of phosphorylated AMPK alpha and the decrease of PEPCK and G6Pase expression caused by phloroglucinol treatment. We conclude that phloroglucinol may inhibit hepatic gluconeogenesis via modulating the AMPK alpha signaling pathway, and thus lower blood glucose levels. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI AG | - |
dc.relation.isPartOf | MARINE DRUGS | - |
dc.title | The Effect of Phloroglucinol, A Component of Ecklonia cava Extract, on Hepatic Glucose Production | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000404228300022 | - |
dc.identifier.doi | 10.3390/md15040106 | - |
dc.identifier.bibliographicCitation | MARINE DRUGS, v.15, no.4 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85018656768 | - |
dc.citation.title | MARINE DRUGS | - |
dc.citation.volume | 15 | - |
dc.citation.number | 4 | - |
dc.contributor.affiliatedAuthor | Yoon, Ji-Young | - |
dc.contributor.affiliatedAuthor | Choi, Hojung | - |
dc.contributor.affiliatedAuthor | Jun, Hee-Sook | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Phloroglucinol | - |
dc.subject.keywordAuthor | gluconeogenesis | - |
dc.subject.keywordAuthor | PEPCK | - |
dc.subject.keywordAuthor | G6Pase | - |
dc.subject.keywordAuthor | AMPK alpha | - |
dc.subject.keywordPlus | ACTIVATED PROTEIN-KINASE | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | BROWN ALGA | - |
dc.subject.keywordPlus | DIABETES-MELLITUS | - |
dc.subject.keywordPlus | MICE | - |
dc.subject.keywordPlus | LIVER | - |
dc.subject.keywordPlus | GLUCONEOGENESIS | - |
dc.subject.keywordPlus | PHLOROTANNINS | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.